Suggested Readings
Caregiver Toolkit
2023 Alzheimer’s disease facts and figures.
Alzheimer’s Association.
The Alzheimer's disease clinical spectrum: diagnosis and management.
Atri A. Med Clin North Am. 2019;103(2):263-293.
Integrating family caregivers of people with Alzheimer's disease and dementias into clinical appointments: identifying potential best practices.
Griffin JM, Riffin C, Havyer RD, et al. J Appl Gerontol. 2020;39(11):1184-1194.
Primary care practitioner perspectives on the role of primary care in dementia diagnosis and care.
Sideman AB, Ma M, Hernandez de Jesus A, et al. JAMA Netw Open. 2023;6(9):e2336030-e2336030.
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial.
Sims JR, Zimmer JA, Evans CD, et al. JAMA. 2023;330(6):512-527.
Lecanemab in early Alzheimer’s disease.
van Dyck CH, Swanson CJ, Aisen P, et al. N Engl J Med. 2023;388(1):9-21.
Clinical impact of microbleeds in patients with Alzheimer’s disease.
Vázquez-Justes D, Aguirregoicoa I, Fernandez L, et al. BMC Geriatrics. 2022;22(1):774.
Clinical Practice Guidelines
Lecanemab: appropriate use recommendations.
Cummings J, Apostolova L, Rabinovici GD, et al. J Prev Alzheimers Dis. 2023;10(3):362-377.
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer’s Association Workgroup National Institute on Aging and the Alzheimer’s Association (NIA-AA)
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease.
Tian M, Civelek AC, Carrio I, et al. Eur J Nucl Med Mol Imaging. 2022;49(3):895-904.
International Nuclear Medicine Consensus on the clinical use of amyloid positron emission tomography in Alzheimer’s disease.
Tian M, Zuo C, Civelek AC, et al. Phenomics. 2023;3(4):375-389.
Linked Resources
Patient and Caregiver Resources
AD8 dementia screening interview
Alzheimer’s Association.
The Alzheimer’s Questionnaire
Mini-Mental State Exam (MMSE) Alzheimer’s / dementia test: administration, accuracy and scoring
Montreal Cognitive Assessment Test (MoCA) for dementia & Alzheimer’s
Standardized Mini-Cog© Instrument
Related activities
Webcast Series
0.25 CME/CE
First Steps Toward Early Diagnosis of MCI or AD
Module 1
Faculty: | Sharon Cohen, MD, FRCPC; Charles P. Vega, MD, FAAFP |
Release: | 04/29/2024 |
Expiration: | 04/29/2025 |
Webcast Series
0.25 CME/CE
When Is It Time to Refer to a Neurologist
Module 2
Faculty: | Sharon Cohen, MD, FRCPC; Charles P. Vega, MD, FAAFP |
Release: | 05/13/2024 |
Expiration: | 05/13/2025 |
Webcast Series
0.25 CME/CE
Educating Patients and Caregivers About Targeted Therapies for Early AD
Module 3
Faculty: | Sharon Cohen, MD, FRCPC; Eric G. Tangalos, MD, FACP, AGSF, CMD |
Release: | 05/27/2024 |
Expiration: | 05/27/2025 |
Webcast Series
0.25 CME/CE
Is the Patient a Candidate for an Antiamyloid Targeted Therapy?
Module 4
Faculty: | Sharon Cohen, MD, FRCPC; Eric G. Tangalos, MD, FACP, AGSF, CMD |
Release: | 06/10/2024 |
Expiration: | 06/10/2025 |
Webcast Series
0.25 CME/CE
Managing AEs of Antiamyloid Therapies
Module 5
Faculty: | Sharon Cohen, MD, FRCPC; Alireza Atri, MD, PhD |
Release: | 07/01/2024 |
Expiration: | 07/01/2025 |
Webcast Series
0.25 CME/CE
Updates to Clinic Infrastructure and Protocols
Module 6
Faculty: | Sharon Cohen, MD, FRCPC; Alireza Atri, MD, PhD |
Release: | 07/15/2024 |
Expiration: | 07/15/2025 |